Dose dependent protective effect of BPC 157 in capasaicin induced rhinitis in rats, European Arch
This compound is strictly intended for laboratory and scientific research use only and is not approved for human consumption, medical treatment, or therapeutic application
Gojkovic et al., 2020), also in colitis ischemia/reperfusion (Duzel et al., 2017), duodenal venous congestion lesions (Drmic et al., 2018), arising from BPC 157 therapy in addition to the deep vein thrombosis (Vukojevic et al., 2018
This is tremendously interesting, but not super relevant to understanding the article
It promotes craving control and food noise reduction while also improving digestion and fat metabolism
The overall magnitude of response to GEP44 (and GEP12, vide infra) was nearly equivalent to the response to Ex-4 (Fig